1. 1) Baker DE. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum. Rev. Gastroenterol. Disord., 3, 31–38 (2003).
2. 2) Pasetto LM, D’Andrea MR, Rossi E, Monfardini S. Oxaliplatin-related neurotoxicity: how and why? Crit. Rev. Oncol. Hematol., 59, 159–168 (2006).
3. 3) Ling B, Coudore F, Decalonne L, Eschalier A, Authier N. Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection. Neuropharmacology, 55, 724–728 (2008).
4. 4) Saif MW, Syrigos K, Kaley K, Isufi I. Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer Res., 30, 2927–2933 (2010).
5. 5) Satoh J, Yagihashi S, Baba M, Suzuki M, Arakawa A, Yoshiyama T, Shoji S. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet. Med., 28, 109–116 (2011).